Drug Store News

View more issues:

Articles in Oct 20, 2003 issue of Drug Store News

• Wal-Mart still bullish on supercenter growth
  by Mike Troy
• Winn-Dixie sees soft first quarter
• CanaRx may curtail import practice, but won't desist
• Eckerd pharmacy school funds help fuel its recruitment efforts
  by James Frederick
• Condition-specific treatment trend drives growth in pain relief segment
  by Michael Johnsen
• General Mills
• Fizzy Lizzy
  by Rob Eder
• Medicare Rx benefit talks inch forward
• Kerr Drug to shutter store
• Shoppers Drug Mart
• MedPointe last month entered a marketing and distribution agreement with AstraZeneca for that company's Zomig family of prescription migraine triptan products
  by James Frederick
• Bristol-Myers Squibb
  by Michael Johnsen
• Markwins Beauty Products
  by Molly Prior
• Baby boomer fad has drug eyeing burgeoning scrapbook business
  by Barbara White-Sax
• ShopKo reveals site for Express Rx stores
  by Laura Heller
• Supermarket unions vote to strike
• Governors look north to cut prescription costs
  by Michael Johnsen
• Teva
  by James Frederick
• Lewin Group
  by Michael Johnsen
• Versatile hairdos spike styling sales
  by Molly Prior
• CoolBrands International
  by Rob Eder
• Navarro adds Healthnotes
• The National Association of Chain Drug Stores
• Novartis Pharmaceuticals
  by James Frederick
• Medicine Shoppe International
  by Michael Johnsen
• Procter & Gamble
  by Molly Prior
• Computer Expressions'
• Caution greets Walgreens' record sales
  by James Frederick
• Ahold posts $1.42 billion loss in '02
• FDA takes aim at counterfeit drugs
  by James Frederick
• Pharmacist's role shifts to caregiver as diabetes education efforts advance
  by Michelle L. Kirsche
• Thermometer sales heat up
  by Michael Johnsen
• The Center for Creative Play
• Wrigley
  by Rob Eder
• Indies file suit against PBMs
• Walgreen Co
• Food and Drug Administration
  by James Frederick
• Diabetes drugs in development reveal transformation in therapy
  by Michelle L. Kirsche
• Schick
  by Molly Prior
• Energizer Holdings
• Food going to the dogs
  by Rob Eder
• Weathering a tough economy, Walgreens maintains its streak
  by James Frederick
• P&G beauty biz blossoms under 'consumer rules'
• Trial continues for former Rite Aid attorney
• Ranbaxy Pharmaceuticals
  by James Frederick
• Pharmavite
  by Michael Johnsen
• Citrus: the new cinnamon
  by Molly Prior
• Celestial Seasonings
  by Rob Eder
• MPA combats union mail order contract
• Blade war moves into the courtroom
  by Molly Prior
• Pathmark Stores
• Bristol-Myers Squibb and QDose
  by James Frederick
• LifeScan
  by Michael Johnsen
• Less expensive cosmetics target cautious consumers in tight economy
  by Molly Prior
• Workout videos fit for the new year
• Sluggish regional economy pummels Duane Reade sales
  by Molly Prior
• Morrison OK'd to buy U.K. Safeway
• Health care fate may be in the wrong hands
  by Tony Lisanti
• Diabetes ushers in new practice mode
  by Michelle L. Kirsche
• CVS and Eckerd
  by Molly Prior
• Tomy Corp
• Hershey Foods
  by Rob Eder
• Fall seasonals drive solid September sales
  by Antoinette Alexander
• Be Medwise writes Rx to engage pharmacists
  by Michael Johnsen
• Eckerd will be better off without J.C. Penney
  by Mike Troy
• 2002 Foundation Dinner Contributors
• Revlon
  by Molly Prior
• Madacy Kids'
• Healthy, berry-flavored options emerge as new favorites in cereal
  by Rob Eder